This map shows the geographic impact of H. M. Pinedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. M. Pinedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. M. Pinedo more than expected).
This network shows the impact of papers produced by H. M. Pinedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. M. Pinedo. The network helps show where H. M. Pinedo may publish in the future.
Co-authorship network of co-authors of H. M. Pinedo
This figure shows the co-authorship network connecting the top 25 collaborators of H. M. Pinedo.
A scholar is included among the top collaborators of H. M. Pinedo based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H. M. Pinedo. H. M. Pinedo is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Eertwegh, Alfons J.M. van den, A.M.E. Claessen, Harm van Tinteren, et al.. (2000). Actieve specifieke immunotherapie als adjuvante behandeling van patiënten met coloncarcinoom in stadium II of III: prospectief gerandomiseerd onderzoek. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 144(6). 274–279.1 indexed citations
7.
Hooijberg, Jan Hendrik, H J Broxterman, George L. Scheffer, et al.. (1999). Potent interaction of flavopiridol with MRP1. British Journal of Cancer. 81(2). 269–276.72 indexed citations
8.
Ozols, Robert F. & H. M. Pinedo. (1999). The fox chase cancer center and free university hospital investigators' workshop and consensus conference on paclitaxel.1 indexed citations
Broxterman, Henricus J., J. Lankelma, & H. M. Pinedo. (1996). How to probe clinical tumor samples for P-glycoprotein and multidrug resistance protein. European Journal of Cancer. 1024–1033.2 indexed citations
12.
López‐López, Rafael, et al.. (1994). Effect of suramin on adenylate cyclase and protein kinase C.. PubMed. 9(4). 279–90.9 indexed citations
13.
Herscheid, Jacobus D. M., et al.. (1994). High yield production of pure 89Zr; A positron emitter for labelling of proteins. Journal of Labelled Compounds and Radiopharmaceuticals. 35. 264–266.2 indexed citations
Peters, Godefridus J., Gilberto Schwartsmann, Jorge Nadal, et al.. (1990). In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.. PubMed. 50(15). 4644–9.74 indexed citations
16.
Groeningen, C.J. van, H.E. Gall, A. C. Van Loenen, et al.. (1989). Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis.. PubMed. 35(5-6). 283–94.1 indexed citations
17.
Neijt, J.P., A.C.M. van Lindert, C. P. J. Vendrik, et al.. (1980). Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.. PubMed. 64(2-3). 323–6.13 indexed citations
18.
Pinedo, H. M.. (1978). Clinical pharmacology of anti-neoplastic drugs. Elsevier eBooks.27 indexed citations
19.
Pinedo, H. M., et al.. (1977). Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(4). 709–15.64 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.